Pharmacy Provider Manuals
Welcome to the Pharmacy Corner
The pharmacy program in Delaware is operationally administered through the Delaware Medical Assistance Program (DMAP). Staffing for the Pharmacy Program includes a Pharmacy Director in conjunction with the DXC Pharmacy Team. The objective of the pharmacy program is to ensure that DMAP members have access to appropriate medications while monitoring utilization and cost-effectiveness. The rapid changes in the pharmacy industry and the importance of communicating new information to the pharmacy community are critical to the quality and continuity of care for Delaware citizens. Please click the links on the left to learn more about the pharmacy program.
Tip of the Day
On February 1, 2019, alprazolam (Xanax) will become non-preferred for DMMA members.
Along with the opioid epidemic, Delaware faces a crisis with deaths related to the use of benzodiazepines. During 2019 DMMA will focus Drug Utilization Review programs and policy changes to address the challenges created by the over prescribing of the medications in this class. The first initiative will focus on alprazolam which will become non-preferred for DMMA members as of February 1, 2019
DMMA members with a history of alprazolam on their drug profile within the last 60 days can have a prior authorization created to allow for an adequate time for an assessment. Practitioners may want to take this opportunity to taper the dosing and to discuss other treatment options with the member.
Drug Rebate Web Invoicing can be viewed through
Delaware Web Invoicing Information. To apply, please complete both the
Memorandum of Understanding for electronic invoicing
Application for electronic invoicing
forms. Prior versions of this material can be found in the
For questions on Web Invoicing, email: MoveItDocumentTransfer@dxc.com
For any questions related to Drug Rebate, email: DEDrugRebate@dxc.com
W-9 for Drug Rebate
Non-Participating State Manufactures